# Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes

> **NCT01107899** · PHASE1 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 29 (actual)

## Conditions studied

- Acute Coronary Syndromes

## Interventions

- **DRUG:** clopidogrel
- **DRUG:** prasugrel

## Key facts

- **NCT ID:** NCT01107899
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Terminated due to Enrollment futility
- **Last updated:** 2012-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01107899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01107899, "Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01107899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*